PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 116 filers reported holding PMV PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154 | +2.7% | 24,944 | +4.1% | 0.00% | – |
| Q2 2023 | $150 | +32.7% | 23,961 | +1.5% | 0.00% | – |
| Q1 2023 | $113 | -29.4% | 23,617 | +28.8% | 0.00% | – |
| Q4 2022 | $160 | -99.9% | 18,339 | +2.7% | 0.00% | – |
| Q3 2022 | $213,000 | -4.1% | 17,864 | +14.4% | 0.00% | – |
| Q2 2022 | $222,000 | -26.5% | 15,613 | +7.6% | 0.00% | – |
| Q1 2022 | $302,000 | -74.5% | 14,504 | -71.7% | 0.00% | – |
| Q4 2021 | $1,183,000 | -73.8% | 51,224 | -66.3% | 0.00% | – |
| Q3 2021 | $4,523,000 | +15.2% | 151,778 | +27.1% | 0.00% | – |
| Q1 2021 | $3,926,000 | – | 119,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |